By Daniella Parra On Running (NYSE: ONON) said first quarter net sales increased by 14.5% from a year earlier, reaching CHF 831.9 million. The company said sales in the Asia-Pacific region grew 44.4%, representing more than 20% of global...

By Karen Roman NanoViricides, Inc. (NYSE: NNVC) said the recent outbreak of the hantavirus on a cruise ship highlights the need for broad-spectrum  antiviral drugs such as NV-387. The hantavirus gets into the lungs through droplets of cough or spit...

Download the Complete Report Here AIR Global PLC (Proposed Ticker: AIIR) Global Flavored Shisha Leader Scaling into Higher-Value, Device-Led Inhalation Platforms AIIR enters public markets as a scaled, cash-generative category leader, offering differentiated exposure to a stable, value-led consumption category...

Download the Complete Report Here The ONE Group Hospitality, Inc. (STKS) Traffic Led Comparable Sales Recovery and Benihana Synergies Continue to Drive Margin Expansion and Free Cash Flow Improvement Key Takeaways Revenue and comparable sales were modestly impacted by softer...

By Jarrett Banks Corpay, Inc. (NYSE: CPAY) delivered the kind of quarter that shifts the narrative from a solid payments company to a potential long-term compounder. Across Wall Street brokerage reports, the themes were the same: accelerating Corporate Payments momentum,...

Download the Complete Report Here Horizon Quantum Holdings Ltd. (HQ) Triple Alpha Progress and Expanding Hardware Ecosystem Reinforce HQ’s Quantum Software Infrastructure Strategy. Key Takeaways: First quarter as a public company reinforced HQ’s positioning as a differentiated quantum software infrastructure...

By Daniella Parra Once Upon A Farm, PBC (NYSE: OFRM) said first quarter net sales increased 44 percent year-over-year to $73 million.  The organic baby food maker said Adjusted EBITDA in the quarter was a loss of $3.1 million compared...

By Daniella Parra Glucotrack, Inc. (Nasdaq: GCTK) said it has submitted an Investigational Device Exemption application to the FDA to begin a U.S. clinical study for its fully implantable continuous blood glucose monitoring technology. The company said it is designed...

By Karen Roman NCR Voyix Corp. (NYSE: VYX) said first quarter revenue was $606 million compared to $612 million the year prior, with diluted EPS of $(0.04) compared to $(0.18). Adjusted EBITDA was $78 million compared to $74 million the...

By Karen Roman The Middleby Corp. (Nasdaq: MIDD) said net sales increased 15 percent in the first quarter to $840 million compared to the year prior. Adjusted EBITDA was $181 million in the quarter compared to $161 million a ;year...